Human genetics testing firm 23andMe announced Tuesday it will voluntarily delist from the Nasdaq and deregister with the U.S.

Bloomberg ETF analyst James Seyffart says the SEC delay in a decision on Ether staking and XRP ETFs was not unexpected.

Nasdaq has filed for crypto asset manager 21Shares to list a spot Sui exchange-traded fund (ETF) in the US, initiating the ...

Nasdaq has officially filed the 19b-4 for 21Shares Sui ETF, which begins the review process for the SEC to approve or deny ...

The SEC has acknowledged BlackRock's filing to amend its Ethereum ETF to allow in-kind redemptions, opening the window for ...

The investigation began under former SEC Chair Gary Gensler and has continued under the current administration, according to ...

The SEC delayed its deadline to decide on multiple spot Solana ETFs in the U.S., but that isn’t necessarily a bad sign, an ...

Discover the most crowded hedge fund trades based on Morgan Stanley's 13F analysis. Learn key stocks & sectors influencing ...

The U.S. Securities and Exchange Commission on Tuesday delayed its decision on cryptocurrency exchange-traded funds linked to ...

The SEC delayed 21Shares' XRP ETF filing, alongside others. Experts remain confident approval will come by late June or early Q4.

XRP underperforms as ETF delays and legal limbo persist. Investors eye May court filings and $3.00 resistance levels.

Explore the latest TRON price prediction as ETF filings and USDT growth hint at a possible rise to $0.60. Stay updated on TRX ...